Incidence, characteristics, management and outcome of patients with follicular lymphoma with tumor epidural compression, a study on 22 cases.

[1]  M. Kumar,et al.  A comparative study of interventions in spinal extranodal Non-Hodgkin's lymphoma: A single-center case series from North India , 2020 .

[2]  V. Seshan,et al.  Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups , 2020, Blood Cancer Journal.

[3]  G. Salles,et al.  Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Anita Burgun-Parenthoine,et al.  A clinician friendly data warehouse oriented toward narrative reports: Dr. Warehouse , 2018, J. Biomed. Informatics.

[5]  A. Ahmed,et al.  Management of extranodal lymphoma of the spine: a study of 30 patients , 2018, CNS oncology.

[6]  D. Rades,et al.  Radiotherapy With 4 Gy × 5 Versus 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009/01). , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  D. Rades,et al.  Radiation Therapy Alone Provides Excellent Outcomes for Spinal Cord Compression from Vertebral Lymphoma. , 2016, Anticancer research.

[8]  L. Stalpers,et al.  Single-Fraction Versus 5-Fraction Radiation Therapy for Metastatic Epidural Spinal Cord Compression in Patients With Limited Survival Prognoses: Results of a Matched-Pair Analysis. , 2015, International journal of radiation oncology, biology, physics.

[9]  L. Specht,et al.  Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. , 2015, International journal of radiation oncology, biology, physics.

[10]  P. Hoskin,et al.  4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial. , 2014, The Lancet. Oncology.

[11]  A. Hagenbeek,et al.  Updated 6 Year Follow-Up Of The PRIMA Study Confirms The Benefit Of 2-Year Rituximab Maintenance In Follicular Lymphoma Patients Responding To Frontline Immunochemotherapy , 2013 .

[12]  Y. Yamada,et al.  The NOMS framework: approach to the treatment of spinal metastatic tumors. , 2013, The oncologist.

[13]  Y. M. van der Linden,et al.  Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. , 2012, International journal of radiation oncology, biology, physics.

[14]  P. Hoskin,et al.  Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  Andrew Lister,et al.  Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial , 2011, The Lancet.

[16]  Alexandra G. Smith,et al.  Epidemiology of lymphomas , 2011, Histopathology.

[17]  Giovanni Martinelli,et al.  Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Horning,et al.  Follicular lymphoma: clinical features and treatment. , 2008, Hematology/oncology clinics of North America.

[19]  W. Sze,et al.  Palliative radiotherapy trials for bone metastases: a systematic review. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Mohammed Mohiuddin,et al.  Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial , 2005, The Lancet.

[21]  A. Avilés,et al.  Spinal Cord Compression as a Primary Manifestation of Aggressive Malignant Lymphomas: Long-term Analysis of Treatments with Radiotherapy, Chemotherapy or Combined Therapy , 2002, Leukemia & lymphoma.

[22]  P. Sanders,et al.  Local control and survival in spinal cord compression from lymphoma and myeloma. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.